Machine Learning-Based Approach to Developing Potent EGFR Inhibitors for Breast CancerDesign, Synthesis, and In Vitro Evaluation

• Hossam Nada,
• Anam Rana Gul,
• Ahmed Elkamhawy,
• Sungdo Kim,
• Minkyoung Kim,
• Yongseok Choi,
• Tae Jung Park,
• Kyeong Lee

Affiliations

Hossam Nada

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea

Anam Rana Gul

Department of Chemistry, Chung-Ang University, Seoul, South Korea

Ahmed Elkamhawy

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea

Sungdo Kim

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea

Minkyoung Kim

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea

Yongseok Choi

College of Life Sciences and Biotechnology, Korea University, Seoul, Republic of Korea

Tae Jung Park

Department of Chemistry, Chung-Ang University, Seoul, South Korea

Kyeong Lee

BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Republic of Korea